List view / Grid view
Meet our new advisor, Dr Remco Jan Geukes Foppen, an…
22 September 2025 | By
Meet our new advisor, Dr Remco Jan Geukes Foppen, an AI and life sciences expert driving global innovation in pharma with expertise in data, bioinformatics and clinical trial AI.
AI is increasingly used in drug discovery, but hidden bias…
AI is increasingly used in drug discovery, but hidden bias and ‘black box’ models threaten trust and transparency. This article explores how explainable AI can turn opaque predictions into clear, accountable insights.
Drug development has long been hindered by fragmented data and…
Drug development has long been hindered by fragmented data and complex processes, but a new wave of AI is reshaping the landscape. By integrating genomic, clinical and molecular data, multimodal models are revealing hidden patterns and accelerating more precise advancements in medicine.
Drug development is plagued by high costs, long timelines and…
Drug development is plagued by high costs, long timelines and low success rates, but what if AI could change that? Read on to discover real-world examples and explore the transformative potential of AI in drug development.
AI-driven drug development, powered by advanced models and expanding data…
AI-driven drug development, powered by advanced models and expanding data access, is becoming a reality. Learn why navigating regulatory hurdles and mastering biology’s inherent complexities are crucial to fully unlocking its potential.
